Answers are grounded in this paper and cite their sources.
INTRODUCTION: Alzheimer's disease (AD) exhibits substantial molecular heterogeneity. Identifying biologically distinct proteomic states may improve understanding of disease heterogeneity and support precision diagnostics. METHODS: Cerebrospinal fluid proteomic data from ADNI were analyzed. Among 6,361proteins tested between cognitively normal and AD groups, 407 remained significant after Benjamini-Hochberg correction (FDR < 0.05), with 404 retained after missingness filtering. Following preprocessing and outlier removal, 130 individuals were included. Diffusion geometry and persistent homology were applied to characterize intrinsic proteomic structure without predefined clusters. The framework was further evaluated in an independent mass spectrometry cohort. RESULTS: Persistent homology revealed multiscale organization of the AD proteomic landscape. At the selected H0 filtration scale, two dominant proteomic states (n = 71 and n = 42) contained most individuals, alongside smaller components. H1 persistence identified nontrivial cyclic structure, indicating continuous higher-order organization beyond discrete state partitions. The dominant states exhibited distinct proteomic profiles and differed substantially in tau-related biomarkers. Elevated tau pathology in one state was reproduced in the independent cohort, whereas Aβ42 differences were less consistent across cohorts. DISCUSSION: AD proteomic heterogeneity is characterized by multiscale organization combining dominant group structure with continuous higher-order relationships.
No takes yet. Share an insight, caveat, or question.
Shahu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: